ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 8.97
(-0.44%)
CNY 8.97
(-0.44%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 479.72 Million CNY | 10.53% |
| 2022 | 434.03 Million CNY | 23.48% |
| 2021 | 351.51 Million CNY | 31.29% |
| 2020 | 267.74 Million CNY | 38.32% |
| 2019 | 193.57 Million CNY | 33.24% |
| 2018 | 145.28 Million CNY | 1.72% |
| 2017 | 142.82 Million CNY | 54.45% |
| 2016 | 92.47 Million CNY | 34.29% |
| 2015 | 68.86 Million CNY | 207.68% |
| 2014 | 22.38 Million CNY | 113.28% |
| 2013 | 10.49 Million CNY | -82.18% |
| 2012 | 58.89 Million CNY | -21.51% |
| 2011 | 75.03 Million CNY | 18.11% |
| 2010 | 63.52 Million CNY | 30.28% |
| 2009 | 48.76 Million CNY | 26.67% |
| 2008 | 38.49 Million CNY | 229.13% |
| 2007 | 11.69 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 61.24 Million CNY | 58.69% |
| 2024 Q1 | 38.59 Million CNY | -52.57% |
| 2024 Q3 | -37.22 Million CNY | -160.79% |
| 2023 Q4 | 81.36 Million CNY | -18.39% |
| 2023 FY | 479.72 Million CNY | 10.53% |
| 2023 Q1 | 135.04 Million CNY | 38.83% |
| 2023 Q2 | 163.61 Million CNY | 21.15% |
| 2023 Q3 | 99.7 Million CNY | -39.06% |
| 2022 Q2 | 133.47 Million CNY | 24.83% |
| 2022 Q3 | 96.36 Million CNY | -27.8% |
| 2022 Q4 | 97.27 Million CNY | 0.94% |
| 2022 FY | 434.03 Million CNY | 23.48% |
| 2022 Q1 | 106.92 Million CNY | 16.35% |
| 2021 Q4 | 91.9 Million CNY | 29.59% |
| 2021 FY | 351.51 Million CNY | 31.29% |
| 2021 Q1 | 78.04 Million CNY | 25.69% |
| 2021 Q2 | 110.65 Million CNY | 41.77% |
| 2021 Q3 | 70.91 Million CNY | -35.91% |
| 2020 Q2 | 91.39 Million CNY | 50.72% |
| 2020 Q1 | 60.64 Million CNY | 32.06% |
| 2020 Q3 | 53.6 Million CNY | -41.35% |
| 2020 FY | 267.74 Million CNY | 38.32% |
| 2020 Q4 | 62.09 Million CNY | 15.84% |
| 2019 Q3 | 36.62 Million CNY | -41.87% |
| 2019 FY | 193.57 Million CNY | 33.24% |
| 2019 Q1 | 48.01 Million CNY | 176.98% |
| 2019 Q2 | 63 Million CNY | 31.22% |
| 2019 Q4 | 45.92 Million CNY | 25.38% |
| 2018 FY | 145.28 Million CNY | 1.72% |
| 2018 Q4 | 17.33 Million CNY | -48.03% |
| 2018 Q3 | 33.35 Million CNY | -29.82% |
| 2018 Q2 | 47.53 Million CNY | 1.01% |
| 2018 Q1 | 47.05 Million CNY | 74.6% |
| 2017 Q4 | 26.95 Million CNY | -27.87% |
| 2017 Q2 | 43.82 Million CNY | 26.33% |
| 2017 Q1 | 34.69 Million CNY | 166.23% |
| 2017 FY | 142.82 Million CNY | 54.45% |
| 2017 Q3 | 37.36 Million CNY | -14.74% |
| 2016 Q3 | 28.41 Million CNY | -18.88% |
| 2016 FY | 92.47 Million CNY | 34.29% |
| 2016 Q1 | 16 Million CNY | -17.92% |
| 2016 Q2 | 35.02 Million CNY | 118.88% |
| 2016 Q4 | 13.03 Million CNY | -54.14% |
| 2015 Q1 | 4.92 Million CNY | -48.56% |
| 2015 FY | 68.86 Million CNY | 207.68% |
| 2015 Q2 | 35.79 Million CNY | 626.64% |
| 2015 Q3 | 8.64 Million CNY | -75.86% |
| 2015 Q4 | 19.49 Million CNY | 125.65% |
| 2014 Q3 | 6.29 Million CNY | 132.88% |
| 2014 Q4 | 9.57 Million CNY | 52.15% |
| 2014 FY | 22.38 Million CNY | 113.28% |
| 2014 Q1 | 3.8 Million CNY | -54.29% |
| 2014 Q2 | 2.7 Million CNY | -28.96% |
| 2013 Q4 | 8.32 Million CNY | 178.82% |
| 2013 Q2 | 1.57 Million CNY | -85.88% |
| 2013 Q1 | 11.15 Million CNY | -40.92% |
| 2013 FY | 10.49 Million CNY | -82.18% |
| 2013 Q3 | -10.56 Million CNY | -770.62% |
| 2012 Q3 | 741.22 Thousand CNY | -95.68% |
| 2012 Q1 | 22.09 Million CNY | 15.93% |
| 2012 Q4 | 18.88 Million CNY | 2447.55% |
| 2012 FY | 58.89 Million CNY | -21.51% |
| 2012 Q2 | 17.17 Million CNY | -22.25% |
| 2011 Q1 | 30.62 Million CNY | 84.57% |
| 2011 FY | 75.03 Million CNY | 18.11% |
| 2011 Q4 | 19.05 Million CNY | 8.26% |
| 2011 Q3 | 17.6 Million CNY | 127.43% |
| 2011 Q2 | 7.74 Million CNY | -74.73% |
| 2010 FY | 63.52 Million CNY | 30.28% |
| 2010 Q2 | 8.58 Million CNY | -63.26% |
| 2010 Q3 | 14.97 Million CNY | 74.46% |
| 2010 Q4 | 16.59 Million CNY | 10.79% |
| 2010 Q1 | 23.36 Million CNY | 82.14% |
| 2009 FY | 48.76 Million CNY | 26.67% |
| 2009 Q3 | 5.95 Million CNY | 0.0% |
| 2009 Q4 | 12.82 Million CNY | 115.4% |
| 2008 FY | 38.49 Million CNY | 229.13% |
| 2007 FY | 11.69 Million CNY | 0.0% |